Loading...
Reach Banner
Keywords
Last name
Institution

Petros Pechlivanoglou

TitleScientist
InstitutionThe Hospital for Sick Children
DepartmentChild Health Evaluative Sciences
Address555 University Avenue
Toronto ON M5G 1X8
Phone416-813-1500
vCardDownload vCard

    Collapse Biography 
    Collapse education and training
    Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto12/2015Postdoctoral Fellow
    Unit of Pharmacoepidemiology and Pharmacoeconomics, Faculty of Pharmacy, University of Groningen, Groningen, The NetherlandsPhD12/2012Pharmacoeconomics
    Faculty of Economics, University of Groningen, Groningen, The NetherlandsMSc06/2007Econometrics
    Faculty of Economic Sciences, University of Macedonia, Thessaloniki, GreeceBSc09/2005Economics
    Collapse awards and honors
    2019The Nancy E.T. Fahrner Award, The Hospital for Sick Children
    2017 - 2018Greek Diaspora Fellowship, The Stavros Niarchos Foundation, Greece
    2007 - 2010Dutch Bursary Ph.D. Scholarship, Groningen University, The Netherlands

    Collapse Overview 
    Collapse overview
    Petros Pechlivanoglou, PhD, is a Scientist at The Hospital for Sick Children (SickKids) Research Institute and an Assistant Professor at the University of Toronto, Institute of Health Policy Management and Evaluation. He studied economics in his native country, Greece, econometrics at the University of Groningen, the Netherlands and obtained a PhD in health econometrics from the same university. He completed a post-doctoral fellowship at the University of Toronto, within the Toronto Health Economics and Technology Assessment (THETA) Collaborative where he focused on methodological aspects around the application of decision analysis in health-care policy.

    Research Interests: Use of decision analysis in health care, Development of prediction models for economic evaluation, Application of evidence synthesis methods in health economics, Use of real-world evidence in economic evaluation

    Research Activities: Pechlivanoglou's research activities currently are centred on the use of health decision analysis in economic evaluation; bridging evidence synthesis, administrative data and decision analysis; the application and extension of predictive models in health economics as well as other econometric and statistical applications in health economics and health policy, such as the estimation of empirical cost-effectiveness thresholds. He is currently involved in projects around the economics of pre-term birth prevention, the economic evaluation of oncology and ophthalmic interventions in children and adolescents and the economic impact of obstructive sleep apnea and COPD in adults.


    Collapse Research 
    Collapse research activities and funding
         (Maarten Postma)Jun 1, 2011 - Jun 1, 2012
    Merck, Sharp and Dohme UK
    Economic evaluation of a network of alternative prophylaxis strategies in high-risk neutropenic patients in the Netherlands
    Role: Co-Applicant

         (Maarten Postma)Jan 1, 2012 - Dec 31, 2012
    Health Council of the Netherlands
    Economic evaluation of a network of new antithrombotic drugs
    Role: Co-Applicant

         (Murray Krahn)Apr 1, 2014 - Mar 31, 2015
    Health Quality Ontario
    Toronto Health Economics and Technology Assessment Collaborative (THETA)
    Role: Co-Applicant

         (Petros Pechlivanoglou)Apr 1, 2014 - Mar 31, 2024
    Ministry of Research and Innovation, Government of Ontario
    Ontario Early Researcher Award: Developing the Pediatric Oncology Simulation Model
    Role: Principal Investigator

         (Murray Krahn)Jul 1, 2014 - Jun 30, 2017
    Ministry of Health and Long-Term Care, Ontario, Rx&D and the Ontario Lung Association (OLA)
    Evaluation of Value Demonstrating Initiative on COPD
    Role: Co-Applicant

         (Murray Krahn)Jul 1, 2014 - Jun 30, 2017
    Ministry of Health and Long-Term Care, Ontario, Rx&D and the Ontario Lung Association (OLA)
    Evaluation of Value Demonstrating Initiative on COPD
    Role: Co-Applicant

         (William Wong; Murray Krahn)Oct 1, 2014 - Sep 30, 2015
    Canadian Institutes of Health Research (CIHR)
    Cross sectional and longitudinal measures of quality of life and utility among patients with chronic hepatitis C virus infection
    Role: Co-Applicant

         (Wendy Hatch)Jan 1, 2015 - Jan 1, 2016
    University of Toronto
    Evaluating the cost-effectiveness of corneal cross-linking in the treatment of keratoconus in Ontario
    Role: Co-Applicant

         (Murray Krahn)Dec 1, 2015 - Oct 1, 2013
    The Blueprint for Pharmacy c/o The Canadian Pharmacists Association
    Clinical and cost-effectiveness of MedsCheck in Ontario seniors: A mixed methods study
    Role: Co-Applicant

         (William Wei Wong)Jul 1, 2016 - Jun 30, 2019
    Canadian Institutes of Health Research (CIHR) Project Scheme
    Understanding the treatment benefits of novel antiviral agents for hepatitis C: Quality of life, health utility, cost, and return to work
    Role: Co-Applicant

         (Cynthia Hawkins; John Racher)Oct 1, 2016 - Sep 30, 2019
    Genomic Applications Partnership Program
    Clinical development and translation of genomics-driven paediatric cancer diagnostics using NanoString Technology
    Role: Collaborator

         (Petros Pechlivanoglou)Nov 1, 2016 - Oct 31, 2017
    POGO Seed Funding Grant
    Economic evaluation of chimeric antigen receptor T-cells (CART) therapy for high-risk relapsed acute lymphoblastic leukemia in children
    Role: Principal Investigator

         (Petros Pechlivanoglou; Prakeshkumar Shah)Nov 1, 2016 - Oct 31, 2021
    Canadian Institutes of Health Research (CIHR)
    Improving Outcomes for Preterm Infants and their Families: A Canadian Collaborative Network
    Role: Principal Investigator

         (Petros Pechlivanoglou)Jan 1, 2017 - Jan 1, 2019
    Canadian Respiratory Research Network Project Grant
    Creating a platform for prediction of real-world health and cost consequences of COPD
    Role: Principal Investigator

         (Petros Pechlivanoglou; Terry Paul Klassen)Jan 1, 2017 - Dec 31, 2020
    Canadian Institutes of Health Research (CIHR). SPOR Innovative Clinical Trials
    Innovation in Pediatric Clinical Trials (IPCT)
    Role: Principal Investigator

         (Kelvin Chan, Wanrudee Isaranuwatchai, Stuart James Peacock, Michael David Sherar)Mar 1, 2017 - Feb 28, 2018
    Canadian Institutes of Health Research (CIHR), Catalyst Grant: Health Services and Economics Research in Cancer Control
    A Multi-Province Approach to Real World Evidence Development for Cancer Drugs: A Case Study of Melanoma
    Role: Co-Applicant

         (Petros Pechlivanoglou; Eldon Spackman)Mar 31, 2017 - Feb 28, 2018
    Canadian Institutes of Health Research (CIHR) Institute of Cancer Research (ICR) Catalyst Grant: Health Services and Economics Research in Cancer Control
    Estimating the cost-effectiveness threshold for cancer care in Alberta
    Role: Principal Investigator

         (Kelvin Chan)Jul 1, 2017 - Jun 30, 2021
    Canadian Institutes of Health Research (CIHR) Operating Grant: Partnerships for Health System Improvement for Cancer Control
    Developing a framework for the incorporation of real world evidence into cancer drug funding decisions in Canada
    Role: Co-Applicant

         (Sumit Gupta)Nov 1, 2017 - Oct 31, 2019
    Children's Cancer and Blood Disorders C17 Research Network Grant
    Healthcare utilization and costs associated with current and future treatment strategies for childhood acute lymphoblastic leukemia: Building a policy model for clinicians and funders
    Role: Co-Applicant

         (Paul Nathan)Jun 1, 2018 - May 31, 2026
    Canadian Institutes of Health Research (CIHR)
    Optimizing outcomes in survivors of childhood, adolescent and young adult cancer.
    Role: Co-Applicant

         (Paul Nathan)Sep 1, 2018 - Aug 31, 2020
    Cancer Research Society
    Performance and cost-effectiveness of a prediction tool to identify cancer predisposition syndromes in children with cancer
    Role: Co-Applicant

         (Catherine Goudie)Sep 1, 2018 - Aug 31, 2021
    Canadian Institutes of Health Research (CIHR) Project Grant
    Rationalizing Genetic Referral Practices in Pediatric Oncology: An eHealth Decision-Support Tool for Identifying Cancer Predisposition Syndromes
    Role: Principal Investigator

         (Marc Beltempo)Nov 1, 2018 - Oct 31, 2021
    Canadian Institutes of Health Research (CIHR), Early Career Investigator Grants in Maternal, Reproductive, Child & Youth Health
    Optimizing Resource Allocation in the NICU to Improve Outcomes of Very Preterm Infants
    Role: Co-Applicant

         (Wanrudee Isaranuwatchai; Andrea Catherine Tricco)Apr 1, 2019 - Mar 31, 2022
    Canadian Institutes of Health Research (CIHR), Project Grant
    Economic impact of falls prevention interventions: We know the “value”, but what about the “value for money”?
    Role: Co-Applicant

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Heath A, Offringa M, Pechlivanoglou P, Rios JD, Klassen TP, Poonai N, Pullenayegum E. Determining a Bayesian predictive power stopping rule for futility in a non-inferiority trial with binary outcomes. Contemp Clin Trials Commun. 2020 Jun; 18:100561. PMID: 32300671.
      View in: PubMed
    2. Tillmann BW, Nathens AB, Guttman MP, Pequeno P, Scales DC, Pechlivanoglou P, Haas B. Hospital resources do not predict accuracy of secondary trauma triage: A population-based analysis. J Trauma Acute Care Surg. 2020 Feb; 88(2):230-241. PMID: 31999654.
      View in: PubMed
    3. Krijkamp EM, Alarid-Escudero F, Enns EA, Pechlivanoglou P, Hunink MGM, Yang A, Jalal HJ. A Multidimensional Array Representation of State-Transition Model Dynamics. Med Decis Making. 2020 02; 40(2):242-248. PMID: 31989862.
      View in: PubMed
    4. Furzer J, Gupta S, Nathan PC, Schechter T, Pole JD, Krueger J, Pechlivanoglou P. Cost-effectiveness of Tisagenlecleucel vs Standard Care in High-risk Relapsed Pediatric Acute Lymphoblastic Leukemia in Canada. JAMA Oncol. 2020 Jan 23. PMID: 31971547.
      View in: PubMed
    5. Cohn LN, Pechlivanoglou P, Lee Y, Mahant S, Orkin J, Marson A, Cohen E. Health Outcomes of Parents of Children with Chronic Illness: A Systematic Review and Meta-Analysis. J Pediatr. 2020 Mar; 218:166-177.e2. PMID: 31916997.
      View in: PubMed
    6. Furzer J, Tessier L, Hodgson D, Cotton C, Nathan PC, Gupta S, Pechlivanoglou P. Cost-Utility of Early Breast Cancer Surveillance in Survivors of Thoracic Radiation-Treated Adolescent Hodgkin Lymphoma. J Natl Cancer Inst. 2020 Jan 01; 112(1):63-70. PMID: 31070751.
      View in: PubMed
    7. Saeed YA, Phoon A, Bielecki JM, Mitsakakis N, Bremner KE, Abrahamyan L, Pechlivanoglou P, Feld JJ, Krahn M, Wong WWL. A Systematic Review and Meta-Analysis of Health Utilities in Patients With Chronic Hepatitis C. Value Health. 2020 Jan; 23(1):127-137. PMID: 31952667.
      View in: PubMed
    8. Widjaja E, Papastavros T, Sander B, Snead C, Pechlivanoglou P. Early economic evaluation of MRI-guided laser interstitial thermal therapy (MRgLITT) and epilepsy surgery for mesial temporal lobe epilepsy. PLoS One. 2019; 14(11):e0224571. PMID: 31747402.
      View in: PubMed
    9. Krahn MD, Bielecki JM, Bremner KE, de Oliveira C, Almeida N, Clement F, Lorenzetti DL, O'Campo P, Pechlivanoglou P, Tricco AC. Picturing ELSI+: a visual representation of ethical, legal, and social issues, and patient experiences in Health Technology Assessment in Canada. Int J Technol Assess Health Care. 2020; 36(1):40-49. PMID: 31729308.
      View in: PubMed
    10. Abrahamyan L, Huszti E, Bremner KE, Pechlivanoglou P, Mitsakakis N, Krahn M. New Insights into the Epidemiology of Prostate Cancer in Ontario. Cancer Invest. 2019; 37(10):513-523. PMID: 31617759.
      View in: PubMed
    11. Alarid-Escudero F, Krijkamp EM, Pechlivanoglou P, Jalal H, Kao SZ, Yang A, Enns EA. A Need for Change! A Coding Framework for Improving Transparency in Decision Modeling. Pharmacoeconomics. 2019 11; 37(11):1329-1339. PMID: 31549359.
      View in: PubMed
    12. Pelland-Marcotte MC, Tole S, Pechlivanoglou P, Brandão LR. Effectiveness and Safety of Primary Thromboprophylaxis in Children with Cancer: A Systematic Review of the Literature and Network Meta-Analysis. Thromb Haemost. 2019 Dec; 119(12):2034-2042. PMID: 31600808.
      View in: PubMed
    13. Krahn MD, Bremner KE, de Oliveira C, Dixon SN, McFarlane P, Garg AX, Mitsakakis N, Blake PG, Harvey R, Pechlivanoglou P. Home Dialysis Is Associated with Lower Costs and Better Survival than Other Modalities: A Population-Based Study in Ontario, Canada. Perit Dial Int. 2019 Nov-Dec; 39(6):553-561. PMID: 31582466.
      View in: PubMed
    14. Behman R, Nathens AB, Haas B, Look Hong N, Pechlivanoglou P, Karanicolas P. Surgery for adhesive small-bowel obstruction is associated with improved long-term survival mediated through recurrence prevention: A population-based, propensity-matched analysis. J Trauma Acute Care Surg. 2019 09; 87(3):636-644. PMID: 31095068.
      View in: PubMed
    15. Behman R, Nathens AB, Haas B, Look Hong N, Pechlivanoglou P, Karanicolas P. Population-based study of the impact of small bowel obstruction due to adhesions on short- and medium-term mortality. Br J Surg. 2019 12; 106(13):1847-1854. PMID: 31397896.
      View in: PubMed
    16. Lapointe-Shaw L, Bell CM, Austin PC, Abrahamyan L, Ivers NM, Li P, Pechlivanoglou P, Redelmeier DA, Dolovich L. Community pharmacy medication review, death and re-admission after hospital discharge: a propensity score-matched cohort study. BMJ Qual Saf. 2020 01; 29(1):41-51. PMID: 31395749.
      View in: PubMed
    17. Fitzpatrick M, Rac VE, Mitsakakis N, Abrahamyan L, Pechlivanoglou P, Chung S, Carcone SM, Pham B, Kendzerska T, Zwarenstein M, Gottschalk R, George C, Kashgari A, Krahn M. SIESTA - Home sleep study with BresoDx for obstructive sleep apnea: a randomized controlled trial. Sleep Med. 2020 01; 65:45-53. PMID: 31707288.
      View in: PubMed
    18. Aoyama H, Uchida K, Aoyama K, Pechlivanoglou P, Englesakis M, Yamada Y, Fan E. Assessment of Therapeutic Interventions and Lung Protective Ventilation in Patients With Moderate to Severe Acute Respiratory Distress Syndrome: A Systematic Review and Network Meta-analysis. JAMA Netw Open. 2019 Jul 03; 2(7):e198116. PMID: 31365111.
      View in: PubMed
    19. Kelly LE, Richer L, Ali S, Plint AC, Poonai N, Freedman SB, Knisley L, Shimmin C, Hickes S, 't Jong GW, Pechlivanoglou P, Offringa M, Lacaze T, Klassen TP. Innovative approaches to investigator-initiated, multicentre paediatric clinical trials in Canada. BMJ Open. 2019 06 27; 9(6):e029024. PMID: 31253625.
      View in: PubMed
    20. Fung BSC, Behman R, Nguyen MA, Nathens AB, Look Hong NJ, Pechlivanoglou P, Karanicolas PJ. Longer Trials of Non-operative Management for Adhesive Small Bowel Obstruction Are Associated with Increased Complications. J Gastrointest Surg. 2020 Apr; 24(4):890-898. PMID: 31062274.
      View in: PubMed
    21. Behman R, Nathens AB, Mason S, Byrne JP, Hong NL, Pechlivanoglou P, Karanicolas P. Association of Surgical Intervention for Adhesive Small-Bowel Obstruction With the Risk of Recurrence. JAMA Surg. 2019 05 01; 154(5):413-420. PMID: 30698610.
      View in: PubMed
    22. Lee S, Lighvan NL, McCredie V, Pechlivanoglou P, Krahn M, Quiñonez C, Azarpazhooh A. Chlorhexidine-Related Mortality Rate in Critically Ill Subjects in Intensive Care Units: A Systematic Review and Meta-Analysis. Respir Care. 2019 Mar; 64(3):337-349. PMID: 30850551.
      View in: PubMed
    23. Vira T, Pechlivanoglou P, Connelly K, Wijeysundera HC, Roifman I. Cardiac computed tomography and magnetic resonance imaging vs. transoesophageal echocardiography for diagnosing left atrial appendage thrombi. Europace. 2019 Jan 01; 21(1):e1-e10. PMID: 29961869.
      View in: PubMed
    24. Arrospide A, Ramos-Goñi JM, Pechlivanoglou P, Mar J. Application of two-part models and Cholesky decomposition to incorporate covariate-adjusted utilities in probabilistic cost-effectiveness models. Gac Sanit. 2020 Jan - Feb; 34(1):91-95. PMID: 30554736.
      View in: PubMed
    25. Francis T, Kabboul N, Rac V, Mitsakakis N, Pechlivanoglou P, Bielecki J, Alter D, Krahn M. The Effect of Cardiac Rehabilitation on Health-Related Quality of Life in Patients With Coronary Artery Disease: A Meta-analysis. Can J Cardiol. 2019 03; 35(3):352-364. PMID: 30825955.
      View in: PubMed
    26. Behman R, Nathens AB, Look Hong N, Pechlivanoglou P, Karanicolas PJ. Evolving Management Strategies in Patients with Adhesive Small Bowel Obstruction: a Population-Based Analysis. J Gastrointest Surg. 2018 12; 22(12):2133-2141. PMID: 30051307.
      View in: PubMed
    27. Pechlivanoglou P, Paulden M, Pham B, Wong J, Horn SD, Krahn M. Turning High-Risk Individuals: An Economic Evaluation of Repositioning Frequency in Long-Term Care. J Am Geriatr Soc. 2018 07; 66(7):1409-1414. PMID: 29676787.
      View in: PubMed
    28. Krijkamp EM, Alarid-Escudero F, Enns EA, Jalal HJ, Hunink MGM, Pechlivanoglou P. Microsimulation Modeling for Health Decision Sciences Using R: A Tutorial. Med Decis Making. 2018 04; 38(3):400-422. PMID: 29587047.
      View in: PubMed
    29. Shah PS, McDonald SD, Barrett J, Synnes A, Robson K, Foster J, Pasquier JC, Joseph KS, Piedboeuf B, Lacaze-Masmonteil T, O'Brien K, Shivananda S, Chaillet N, Pechlivanoglou P. The Canadian Preterm Birth Network: a study protocol for improving outcomes for preterm infants and their families. CMAJ Open. 2018 Jan 18; 6(1):E44-E49. PMID: 29348260.
      View in: PubMed
    30. Abrahamyan L, Sahakyan Y, Chung S, Pechlivanoglou P, Bielecki J, Carcone SM, Rac VE, Fitzpatrick M, Krahn M. Diagnostic accuracy of level IV portable sleep monitors versus polysomnography for obstructive sleep apnea: a systematic review and meta-analysis. Sleep Breath. 2018 09; 22(3):593-611. PMID: 29318566.
      View in: PubMed
    31. Poon Y, Pechlivanoglou P, Alibhai SMH, Naimark D, Hoch JS, Papadimitropoulos E, Hogan ME, Krahn M. Systematic review and network meta-analysis on the relative efficacy of osteoporotic medications: men with prostate cancer on continuous androgen-deprivation therapy to reduce risk of fragility fractures. BJU Int. 2018 01; 121(1):17-28. PMID: 28921820.
      View in: PubMed
    32. Hollman C, Paulden M, Pechlivanoglou P, McCabe C. A Comparison of Four Software Programs for Implementing Decision Analytic Cost-Effectiveness Models. Pharmacoeconomics. 2017 Aug; 35(8):817-830. PMID: 28488257.
      View in: PubMed
    33. Sahakyan Y, Abrahamyan L, Shahid N, Stanimirovic A, Pechlivanoglou P, Mitsakakis N, Ryan W, Krahn M, Rac VE. Changes in blood pressure among patients in the Ontario Telehomecare programme: An observational longitudinal cohort study. J Telemed Telecare. 2018 Jul; 24(6):420-427. PMID: 28490229.
      View in: PubMed
    34. Leung VC, Pechlivanoglou P, Chew HF, Hatch W. Corneal Collagen Cross-Linking in the Management of Keratoconus in Canada: A Cost-Effectiveness Analysis. Ophthalmology. 2017 08; 124(8):1108-1119. PMID: 28457614.
      View in: PubMed
    35. Jalal H, Pechlivanoglou P, Krijkamp E, Alarid-Escudero F, Enns E, Hunink MGM. An Overview of R in Health Decision Sciences. Med Decis Making. 2017 10; 37(7):735-746. PMID: 28061043.
      View in: PubMed
    36. Pechlivanoglou P, Abrahamyan L, MacKeigan L, Consiglio GP, Dolovich L, Li P, Cadarette SM, Rac VE, Shin J, Krahn M. Factors affecting the delivery of community pharmacist-led medication reviews: evidence from the MedsCheck annual service in Ontario. BMC Health Serv Res. 2016 11 21; 16(1):666. PMID: 27871324.
      View in: PubMed
    37. Tawfik A, Bielecki JM, Krahn M, Dorian P, Hoch JS, Boon H, Husereau D, Pechlivanoglou P. Systematic review and network meta-analysis of stroke prevention treatments in patients with atrial fibrillation. Clin Pharmacol. 2016; 8:93-107. PMID: 27570467.
      View in: PubMed
    38. Dolovich L, Consiglio G, MacKeigan L, Abrahamyan L, Pechlivanoglou P, Rac VE, Pojskic N, Bojarski EA, Su J, Krahn M, Cadarette SM. Uptake of the MedsCheck annual medication review service in Ontario community pharmacies between 2007 and 2013. Can Pharm J (Ott). 2016 Sep; 149(5):293-302. PMID: 27708675.
      View in: PubMed
    39. Tawfik A, Wodchis WP, Pechlivanoglou P, Hoch J, Husereau D, Krahn M. Using Phase-Based Costing of Real-World Data to Inform Decision-Analytic Models for Atrial Fibrillation. Appl Health Econ Health Policy. 2016 Jun; 14(3):313-22. PMID: 26924098.
      View in: PubMed
    40. Stevanovic J, Pechlivanoglou P, Kampinga MA, Krabbe PF, Postma MJ. Multivariate Meta-Analysis of Preference-Based Quality of Life Values in Coronary Heart Disease. PLoS One. 2016; 11(3):e0152030. PMID: 27011260.
      View in: PubMed
    41. Amiche MA, Albaum JM, Tadrous M, Pechlivanoglou P, Lévesque LE, Adachi JD, Cadarette SM. Efficacy of osteoporosis pharmacotherapies in preventing fracture among oral glucocorticoid users: a network meta-analysis. Osteoporos Int. 2016 06; 27(6):1989-98. PMID: 26782683.
      View in: PubMed
    42. Abrahamyan L, Pechlivanoglou P, Krahn M, Carrasco-Labra A, Brignardello-Petersen R, Glick M, Guyatt GH, Azarpazhooh A. Authors' response. J Am Dent Assoc. 2016 Jan; 147(1):6-7. PMID: 26743796.
      View in: PubMed
    43. Amiche MA, Albaum JM, Tadrous M, Pechlivanoglou P, Lévesque LE, Adachi JD, Cadarette SM. Fracture risk in oral glucocorticoid users: a Bayesian meta-regression leveraging control arms of osteoporosis clinical trials. Osteoporos Int. 2016 May; 27(5):1709-18. PMID: 26694595.
      View in: PubMed
    44. Abrahamyan L, Pechlivanoglou P, Krahn M, Carrasco-Labra A, Brignardello-Petersen R, Glick M, Guyatt GH, Azarpazhooh A. A practical approach to evidence-based dentistry: IX: how to appraise and use an article about economic analysis. J Am Dent Assoc. 2015 Sep; 146(9):679-689.e1. PMID: 26314977.
      View in: PubMed
    45. Pechlivanoglou P, Abegaz F, Postma MJ, Wit E. An alternative parameterization of Bayesian logistic hierarchical models for mixed treatment comparisons. Pharm Stat. 2015 Jul-Aug; 14(4):322-31. PMID: 25958984.
      View in: PubMed
    46. Pham B, Tu HA, Han D, Pechlivanoglou P, Miller F, Rac V, Chin W, Tricco AC, Paulden M, Bielecki J, Krahn M. Early economic evaluation of emerging health technologies: protocol of a systematic review. Syst Rev. 2014 Jul 23; 3:81. PMID: 25055987.
      View in: PubMed
    47. Darvishian M, Gefenaite G, Turner RM, Pechlivanoglou P, Van der Hoek W, Van den Heuvel ER, Hak E. After adjusting for bias in meta-analysis seasonal influenza vaccine remains effective in community-dwelling elderly. J Clin Epidemiol. 2014 Jul; 67(7):734-44. PMID: 24768004.
      View in: PubMed
    48. Roessler R, Smallwood SA, Veenvliet JV, Pechlivanoglou P, Peng SP, Chakrabarty K, Groot-Koerkamp MJ, Pasterkamp RJ, Wesseling E, Kelsey G, Boddeke E, Smidt MP, Copray S. Detailed analysis of the genetic and epigenetic signatures of iPSC-derived mesodiencephalic dopaminergic neurons. Stem Cell Reports. 2014 Apr 08; 2(4):520-33. PMID: 24749075.
      View in: PubMed
    49. Stevanovic J, O'Prinsen AC, Verheggen BG, Schuiling-Veninga N, Postma MJ, Pechlivanoglou P. Economic evaluation of primary prevention of cardiovascular diseases in mild hypertension: a scenario analysis for the Netherlands. Clin Ther. 2014 Mar 01; 36(3):368-84.e5. PMID: 24534654.
      View in: PubMed
    50. Pechlivanoglou P, Wieringa JE, de Jager T, Postma MJ. The effect of financial and educational incentives on rational prescribing. A state-space approach. Health Econ. 2015 Apr; 24(4):439-53. PMID: 24519732.
      View in: PubMed
    51. Ivanova SA, Geers LM, Al Hadithy AF, Pechlivanoglou P, Semke AV, Vyalova NM, Rudikov EV, Fedorenko OY, Wilffert B, Bokhan NA, Brouwers JR, Loonen AJ. Dehydroepiandrosterone sulphate as a putative protective factor against tardive dyskinesia. Prog Neuropsychopharmacol Biol Psychiatry. 2014 Apr 03; 50:172-7. PMID: 24389397.
      View in: PubMed
    52. Mihajlovic J, Pechlivanoglou P, Sabo A, Tomic Z, Postma MJ. Cost-effectiveness of everolimus for second-line treatment of metastatic renal cell carcinoma in Serbia. Clin Ther. 2013 Dec; 35(12):1909-22. PMID: 24238790.
      View in: PubMed
    53. Pechlivanoglou P, Le HH, Daenen S, Snowden JA, Postma MJ. Mixed treatment comparison of prophylaxis against invasive fungal infections in neutropenic patients receiving therapy for haematological malignancies: a systematic review. J Antimicrob Chemother. 2014 Jan; 69(1):1-11. PMID: 23975736.
      View in: PubMed
    54. Parouty MB, Krooshof DG, Westra TA, Pechlivanoglou P, Postma MJ. Reviewing and piloting methods for decreasing discount rates; someone, somewhere in time. Expert Rev Pharmacoecon Outcomes Res. 2013 Aug; 13(4):523-47. PMID: 23977978.
      View in: PubMed
    55. Mihajlovic J, Pechlivanoglou P, Miladinov-Mikov M, Zivkovic S, Postma MJ. Cancer incidence and mortality in Serbia 1999-2009. BMC Cancer. 2013 Jan 15; 13:18. PMID: 23320890.
      View in: PubMed
    56. Rozenbaum MH, Pechlivanoglou P, van der Werf TS, Lo-Ten-Foe JR, Postma MJ, Hak E. The role of Streptococcus pneumoniae in community-acquired pneumonia among adults in Europe: a meta-analysis. Eur J Clin Microbiol Infect Dis. 2013 Mar; 32(3):305-16. PMID: 23242464.
      View in: PubMed
    57. Stevanovic J, Postma MJ, Pechlivanoglou P. A systematic review on the application of cardiovascular risk prediction models in pharmacoeconomics, with a focus on primary prevention. Eur J Prev Cardiol. 2012 Aug; 19(2 Suppl):42-53. PMID: 22988567.
      View in: PubMed
    58. Ivanova SA, Loonen AJ, Pechlivanoglou P, Freidin MB, Al Hadithy AF, Rudikov EV, Zhukova IA, Govorin NV, Sorokina VA, Fedorenko OY, Alifirova VM, Semke AV, Brouwers JR, Wilffert B. NMDA receptor genotypes associated with the vulnerability to develop dyskinesia. Transl Psychiatry. 2012 Jan 10; 2:e67. PMID: 22832729.
      View in: PubMed
    59. Pechlivanoglou P, De Vries R, Daenen SM, Postma MJ. Cost benefit and cost effectiveness of antifungal prophylaxis in immunocompromised patients treated for haematological malignancies: reviewing the available evidence. Pharmacoeconomics. 2011 Sep; 29(9):737-51. PMID: 21657801.
      View in: PubMed
    60. Pechlivanoglou P, van der Veen WJ, Bos JH, Postma MJ. Analyzing generic and branded substitution patterns in the Netherlands using prescription data. BMC Health Serv Res. 2011 Apr 27; 11:89. PMID: 21524312.
      View in: PubMed
    61. Luteijn JM, Hubben GA, Pechlivanoglou P, Bonten MJ, Postma MJ. Diagnostic accuracy of culture-based and PCR-based detection tests for methicillin-resistant Staphylococcus aureus: a meta-analysis. Clin Microbiol Infect. 2011 Feb; 17(2):146-54. PMID: 20219085.
      View in: PubMed
    62. Boersma C, Gansevoort RT, Pechlivanoglou P, Visser ST, van Toly FF, de Jong-van den Berg LT, de Jong PE, Postma MJ. Screen-and-treat strategies for albuminuria to prevent cardiovascular and renal disease: cost-effectiveness of nationwide and targeted interventions based on analysis of cohort data from the Netherlands. Clin Ther. 2010 Jun; 32(6):1103-21. PMID: 20637965.
      View in: PubMed
    63. Al Hadithy AF, Ivanova SA, Pechlivanoglou P, Wilffert B, Semke A, Fedorenko O, Kornetova E, Ryadovaya L, Brouwers JR, Loonen AJ. Missense polymorphisms in three oxidative-stress enzymes (GSTP1, SOD2, and GPX1) and dyskinesias in Russian psychiatric inpatients from Siberia. Hum Psychopharmacol. 2010 Jan; 25(1):84-91. PMID: 20041472.
      View in: PubMed
    64. Pechlivanoglou P, Vehof J, van Agthoven M, de Jong-van den Berg LT, Postma MJ. Diffusion of a new drug: a comparative analysis of adoption, treatment complexity, and persistence of risperidone long-acting injectable therapy in the Netherlands. Clin Ther. 2010 Jan; 32(1):108-18. PMID: 20171417.
      View in: PubMed
    65. Al Hadithy AF, Ivanova SA, Pechlivanoglou P, Semke A, Fedorenko O, Kornetova E, Ryadovaya L, Brouwers JR, Wilffert B, Bruggeman R, Loonen AJ. Tardive dyskinesia and DRD3, HTR2A and HTR2C gene polymorphisms in Russian psychiatric inpatients from Siberia. Prog Neuropsychopharmacol Biol Psychiatry. 2009 Apr 30; 33(3):475-81. PMID: 19439249.
      View in: PubMed
    66. Sancar AA, Yegenoglu S, de Vries R, Postma MJ, Simsek N, Pechlivanoglou P, Unal S. Vancomycin vs teicoplanin in the treatment of Gram-positive infections: a pharmacoeconomic analysis in a Turkish University Hospital. Pharm World Sci. 2008 Dec; 30(6):916-23. PMID: 18803030.
      View in: PubMed
    67. Hubben GA, Bishai D, Pechlivanoglou P, Cattelan AM, Grisetti R, Facchin C, Compostella FA, Bos JM, Postma MJ, Tramarin A. The societal burden of HIV/AIDS in Northern Italy: an analysis of costs and quality of life. AIDS Care. 2008 Apr; 20(4):449-55. PMID: 18449822.
      View in: PubMed
    Pechlivanoglou's networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description